Melanoma & Immunotherapy: Ask Dr. Michael Atkins

Dr. Michael Atkins on Immunotherapy or Targeted Therapy as First Treatment for Advanced MelanomaПодробнее

President Carter diagnosed with Melanoma - Dr. Michael Atkins on ABC7Подробнее

Melanoma & Immunotherapy: Ask Dr. Michael AtkinsПодробнее

Michael B. Atkins, MD: New Therapies and New Questions for Metastatic MelanomaПодробнее

Dr. Atkins on Adjuvant Ipilimumab in MelanomaПодробнее

Dr. Atkins Discusses the Adjuvant Treatment of MelanomaПодробнее

Evaluating the Use of Immune Checkpoint Inhibitors in MelanomaПодробнее

Dr. Michael Atkins on Benefits of Adjuvant Treatment in MelanomaПодробнее

Ask the Expert - ImmunotherapyПодробнее

Dr. Michael Atkins at Lombardi Comprehensive Cancer Center and the Academy of Immuno-OncologyПодробнее

Immunotherapy-Related Pulmonary Toxicities in MelanomaПодробнее

Explaining Therapeutic Options to Patients With Advanced MelanomaПодробнее

The future of immunotherapy in melanomaПодробнее

Atkins: Pembrolizumab, Ipilimumab for Melanoma, RCCПодробнее

Ideal Treatment for Melanoma in the Adjuvant SettingПодробнее

How is head and neck cutaneous melanoma treated? (Michael Stadler, MD)Подробнее

Melanoma: Speed and Durability of Therapeutic ResponseПодробнее

Dr. Al Stroberg: Surviving Long after a Melanoma Diagnosis Thanks to ImmunotherapyПодробнее

Patient Selection in Melanoma: Immunotherapy vs Targeted TherapyПодробнее

Side Effects of Immunotherapy in Melanoma - 2022 Program: Melanoma Video LibraryПодробнее